Survivors ( n = 25) | Nonsurvivors ( n = 10) | P value | |
---|---|---|---|
Age (years) | 65 ± 13 | 67 ± 13 | 0.6 |
SAPS II | 47 ± 10 | 53 ± 12 | 0.5 |
SOFA (day 1) | 9 ± 3 | 9 ± 3 | 0.7 |
Heart rate (beats per minute) | 103 ± 15 | 103 ± 12 | 0.9 |
MAP (mmHg) | 81 ± 11 | 69 ± 12 | 0.07 |
Norepinephrine dose (mcg/kg/min) | 0.85 ± 0.65 | 0.93 ± 0.73 | 0.7 |
Hemoglobin (g/dl) | 11.7 ± 1.8 | 9.6 ± 2.1 | 0.1 |
ScvO2 (%) | 71 ± 9 | 71 ± 6 | 0.9 |
Lactate (mg/dl) | 25 ± 10 | 69 ± 83 | 0.8 |
PcvaCO2 gap (mmHg) | 5.4 ± 2.3 | 6.0 ± 1.5 | 0.3 |
PcvaCO2/CavO2 ratio (mmHg · dl/ml O2) | 1.4 ± 0.5 | 1.9 ± 0.9 | 0.03 |
ΔSOFA (day 4) | –3 ± 3 | 1 ± 4 | 0.02 |